FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2079162542> ?p ?o ?g. }

• W2079162542 endingPage "241" @default.
• W2079162542 startingPage "236" @default.
• W2079162542 abstract "Abstract— Photodynamic therapy (PDT) is a cancer treatment modality utilizing a photosensitizer, light and oxygen. Photodynamic therapy with Photofrin® has been approved by the US. Food and Drug Administration for treatment of advanced esophageal and early lung cancer. Because of certain drawbacks associated with the use of Photofrin, there is a need to identify new photosensitizers for human use. The photosensitizer Pc 4 (HOSiPc-OSi[CH3]2[CH2]3N[CH3]2) has yielded promising PDT effects in many in vitro and in vivo systems. The aim of this study was to assess the usefulness of Pc 4 as a PDT photosensitizer for a human tumor grown as a xenograft in athymic nude mice. The ovarian epithelial carcinoma (OVCAR-3) was heterotransplanted subcutaneously in athymic nude mice. Sixty mice bearing OVCAR-3 tumors (∼80–130 mm3) were divided into six groups of 10 animals each, three for controls and three for treatment. The Pc 4 was given by tail vein injection, and 48 h later a 1 cm area encompassing the tumor was irradiated with light from a diode laser coupled to a fiberoptic terminating in a microlens (Λ= 672 nm, 150 J/cm2,150 mW/cm2). Tumors of control animals receiving no treatment, light alone or Pc 4 alone continued to grow. Of animals receiving 0.4 mg/kg Pc 4 and light, one (10%) had a complete response and was cured (no regrowth up to 90 days post-PDT), while all others (90%) had a partial response and were delayed in regrowth. Of animals receiving 0.6 mg/kg Pc 4 and light, eight (80%) had a complete response, and two of these were cured. Of animals receiving 1.0 mg/kg Pc 4 and light, six (60%) had a complete response, and two of these were cured. In additional experiments, tumors from animals treated with Pc 4 (1 mg/kg) and light were removed 15, 30, 60 and 180 min post-PDT, and from these tumors DNA and protein were extracted. Agarose gel electrophoresis revealed the presence of apoptotic DNA fragmentation as early as 15 min post-PDT. Western blotting showed the cleavage of the 116 kDa native poly (ADP-ribose) polymerase (PARP) into fragments of ∼90 kDa, another indication of apoptosis, and the presence of p21/WAFl/CIPl (p21) in all PDT-treated tumors. These changes did not occur in control tumors. Pc 4 appears to be an effective photosensitizer for PDT of human tumors grown as xenografts in nude mice. Early apoptosis, as revealed by PARP cleavage, DNA fragmentation and p21 overexpression, may be responsible for the excellent Pc 4-PDT response. Clinical trials of Pc 4-PDT are warranted." @default.
• W2079162542 created "2016-06-24" @default.
• W2079162542 creator A5016335728 @default.
• W2079162542 creator A5017934215 @default.
• W2079162542 creator A5039950224 @default.
• W2079162542 creator A5043087658 @default.
• W2079162542 creator A5051982352 @default.
• W2079162542 creator A5054813698 @default.
• W2079162542 creator A5056628915 @default.
• W2079162542 creator A5082425428 @default.
• W2079162542 date "1999-02-01" @default.
• W2079162542 modified "2023-10-03" @default.
• W2079162542 title "Phthalocyanine 4 (Pc 4) Photodynamic Therapy of Human OVCAR-3 Tumor Xenografts" @default.
• W2079162542 cites W1969172805 @default.
• W2079162542 cites W1970039444 @default.
• W2079162542 cites W1984058236 @default.
• W2079162542 cites W1992572186 @default.
• W2079162542 cites W1995281577 @default.
• W2079162542 cites W1998424046 @default.
• W2079162542 cites W2010298858 @default.
• W2079162542 cites W2022259405 @default.
• W2079162542 cites W2028224679 @default.
• W2079162542 cites W2031545502 @default.
• W2079162542 cites W2032063521 @default.
• W2079162542 cites W2033590940 @default.
• W2079162542 cites W2034824476 @default.
• W2079162542 cites W2047697738 @default.
• W2079162542 cites W2067896742 @default.
• W2079162542 cites W2083440657 @default.
• W2079162542 cites W2086405807 @default.
• W2079162542 cites W2091210609 @default.
• W2079162542 cites W2109344294 @default.
• W2079162542 cites W2115868186 @default.
• W2079162542 cites W2164733112 @default.
• W2079162542 cites W2165021798 @default.
• W2079162542 cites W2315250335 @default.
• W2079162542 cites W2325628170 @default.
• W2079162542 cites W4211024586 @default.
• W2079162542 cites W4246832840 @default.
• W2079162542 cites W4293241248 @default.
• W2079162542 doi "https://doi.org/10.1111/j.1751-1097.1999.tb03280.x" @default.
• W2079162542 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10048316" @default.
• W2079162542 hasPublicationYear "1999" @default.
• W2079162542 type Work @default.
• W2079162542 sameAs 2079162542 @default.
• W2079162542 citedByCount "101" @default.
• W2079162542 countsByYear W20791625422013 @default.
• W2079162542 countsByYear W20791625422014 @default.
• W2079162542 countsByYear W20791625422015 @default.
• W2079162542 countsByYear W20791625422016 @default.
• W2079162542 countsByYear W20791625422017 @default.
• W2079162542 countsByYear W20791625422018 @default.
• W2079162542 countsByYear W20791625422019 @default.
• W2079162542 countsByYear W20791625422020 @default.
• W2079162542 countsByYear W20791625422021 @default.
• W2079162542 countsByYear W20791625422022 @default.
• W2079162542 countsByYear W20791625422023 @default.
• W2079162542 crossrefType "journal-article" @default.
• W2079162542 hasAuthorship W2079162542A5016335728 @default.
• W2079162542 hasAuthorship W2079162542A5017934215 @default.
• W2079162542 hasAuthorship W2079162542A5039950224 @default.
• W2079162542 hasAuthorship W2079162542A5043087658 @default.
• W2079162542 hasAuthorship W2079162542A5051982352 @default.
• W2079162542 hasAuthorship W2079162542A5054813698 @default.
• W2079162542 hasAuthorship W2079162542A5056628915 @default.
• W2079162542 hasAuthorship W2079162542A5082425428 @default.
• W2079162542 hasConcept C142724271 @default.
• W2079162542 hasConcept C150903083 @default.
• W2079162542 hasConcept C178790620 @default.
• W2079162542 hasConcept C185592680 @default.
• W2079162542 hasConcept C202751555 @default.
• W2079162542 hasConcept C207001950 @default.
• W2079162542 hasConcept C2777546739 @default.
• W2079162542 hasConcept C2781323092 @default.
• W2079162542 hasConcept C2781469039 @default.
• W2079162542 hasConcept C502942594 @default.
• W2079162542 hasConcept C55493867 @default.
• W2079162542 hasConcept C71924100 @default.
• W2079162542 hasConcept C75473681 @default.
• W2079162542 hasConcept C86803240 @default.
• W2079162542 hasConceptScore W2079162542C142724271 @default.
• W2079162542 hasConceptScore W2079162542C150903083 @default.
• W2079162542 hasConceptScore W2079162542C178790620 @default.
• W2079162542 hasConceptScore W2079162542C185592680 @default.
• W2079162542 hasConceptScore W2079162542C202751555 @default.
• W2079162542 hasConceptScore W2079162542C207001950 @default.
• W2079162542 hasConceptScore W2079162542C2777546739 @default.
• W2079162542 hasConceptScore W2079162542C2781323092 @default.
• W2079162542 hasConceptScore W2079162542C2781469039 @default.
• W2079162542 hasConceptScore W2079162542C502942594 @default.
• W2079162542 hasConceptScore W2079162542C55493867 @default.
• W2079162542 hasConceptScore W2079162542C71924100 @default.
• W2079162542 hasConceptScore W2079162542C75473681 @default.
• W2079162542 hasConceptScore W2079162542C86803240 @default.
• W2079162542 hasIssue "2" @default.
• W2079162542 hasLocation W20791625421 @default.
• W2079162542 hasLocation W20791625422 @default.
• W2079162542 hasOpenAccess W2079162542 @default.

• next